EXECUTIVE PROJECT, PROGRAM & PORTFOLIO MANAGEMENT SUMMIT
Master Strategic Decision-Making in Biopharma R&D
Success in pharmaceutical R&D depends on smart portfolio prioritization, risk mitigation, and data-driven decision-making. Designed for senior leaders in R&D, portfolio strategy, program leadership, and enterprise decision support, EP3M moves beyond theory to focus on how decisions actually get made—and how to improve the rigor, speed, transparency, and strategic alignment of those decisions at scale.
What You'll Gain at EP3M Summit?
✅ Executive-Level Insight – Learn from senior pharma and biotech leaders who are modernizing portfolio governance, decision rights, and investment frameworks to improve R&D productivity and portfolio value.
✅ Advanced Analytics & AI in Pracitce – Explore how leading organizations are applying decision science, advanced analytics, and AI to improve portfolio visibility and decision quality—while keeping human judgment at the center.
✅ Real-World Approaches – Take home practical models for portfolio prioritization, governance design, scenario planning, and cross-functional decision forums—grounded in real operating environments, not theory.
✅ Actionable Operating Models – Learn how high-performing organizations structure portfolio review cadences, decision forums, prioritization criteria, and escalation pathways that actually work in practice..
✅ High-Value Peer Exchange – Engage with senior-level peers in a focused, executive setting designed for candid discussion, problem-solving, and long-term professional connection.
✅ Leadership & Career Impact – Strengthen your effectiveness at the leadership table by sharpening how you frame portfolio trade-offs, influence investment decisions, and communicate risk, value, and strategic intent.
“When you can find a PPM conference where on Day 1 you say to yourself, 'these people get it,' that's the kind of conference you return to year after year. It's a mix of industry veterans with different paths into the PPM field that make for incredibly powerful and diverse conversations.”
- Oscar Gonzalez, CEO & President, Sigma Lab Consulting LLC
“There’s a lot to learn from each other to see what others have tried and failed, tried and succeeded and exchange on these topics. I think with a fast-moving environment it is critical, as an industry, that we stay connected.”
- Ivan Kugner, Vice President & Head of Global Portfolio Management, Valuation & Analytics, Merck KGa
